Anti-VEGF-Aptamer Modified C-Dots—A Hybrid Nanocomposite for Topical Treatment of Ocular Vascular Disorders

Asaf Shoval, Amos Markus, Zhixin Zhou, Xia Liu, Rémi Cazelles, Itamar Willner*, Yossi Mandel

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'Anti-VEGF-Aptamer Modified C-Dots—A Hybrid Nanocomposite for Topical Treatment of Ocular Vascular Disorders'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Chemical Engineering

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases